Keith Norris to Calcium
This is a "connection" page, showing publications Keith Norris has written about Calcium.
Connection Strength
0.655
-
Gupta A, Wang J, Norris K. Serum calcium and total calcium load in kidney disease. Nephrol News Issues. 2003 Nov; 17(12):68-70, 72-4, 76 passim.
Score: 0.193
-
Norris KC. The impact of calcium in phosphorus management. Excess calcium load in chronic renal failure adds risk for patients. Nephrol News Issues. 2001 Nov; 15(12):17, 20, 23-4 passim.
Score: 0.168
-
Kalantar-Zadeh K, Miller JE, Kovesdy CP, Mehrotra R, Lukowsky LR, Streja E, Ricks J, Jing J, Nissenson AR, Greenland S, Norris KC. Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients. J Bone Miner Res. 2010 Dec; 25(12):2724-34.
Score: 0.077
-
Norris KC, Nemeh MN, Kert CJ, Muallem S, Levine BS. Basal and stimulated cytosolic platelet calcium in essential hypertension. J Hum Hypertens. 1990 Apr; 4(2):110-2.
Score: 0.075
-
Vassalotti JA, Uribarri J, Chen SC, Li S, Wang C, Collins AJ, Calvo MS, Whaley-Connell AT, McCullough PA, Norris KC. Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2008 Apr; 51(4 Suppl 2):S56-68.
Score: 0.065
-
Friedman TC, Norris KC. The role of vitamin D in mild to moderate chronic kidney disease. Trends Endocrinol Metab. 2002 Jul; 13(5):189-94.
Score: 0.044
-
Norris KC, Crooks PW, Nebeker HG, Hercz G, Milliner DS, Gerszi K, Slatopolsky E, Andress DL, Sherrard DJ, Coburn JW. Clinical and laboratory features of aluminum-related bone disease: differences between sporadic and "epidemic" forms of the syndrome. Am J Kidney Dis. 1985 Nov; 6(5):342-7.
Score: 0.014
-
Fraz?o JM, Elangovan L, Maung HM, Chesney RW, Acchiardo SR, Bower JD, Kelley BJ, Rodriguez HJ, Norris KC, Robertson JA, Levine BS, Goodman WG, Gentile D, Mazess RB, Kyllo DM, Douglass LL, Bishop CW, Coburn JW. Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism. Am J Kidney Dis. 2000 Sep; 36(3):550-61.
Score: 0.010
-
Coburn JW, Salusky IB, Norris KC, Goodman WG. Oral and parenteral calcitriol for the management of end-stage renal disease. Contrib Nephrol. 1991; 90:166-82.
Score: 0.005
-
Andress DL, Norris KC, Coburn JW, Slatopolsky EA, Sherrard DJ. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med. 1989 Aug 03; 321(5):274-9.
Score: 0.004